Skip to main content
. 2021 Feb 11;16(3):396–406. doi: 10.2215/CJN.09280620

Table 4.

Performance of the recurrent neural network model after ablation of the feature set

Outcome Models Area Under the Receiver Operating Characteristic Curve (95% Confidence Interval) Δ Area Under the Receiver Operating Characteristic Curve Area Under the Precision-Recall Curve (95% Confidence Interval) Δ Area Under the Precision-Recall Curve
IDH-1 Remove set A 0.94 (0.94 to 0.94) 0 0.62 (0.61 to 0.62) 0
Remove set B 0.93 (0.93 to 0.93) 0.01 0.60 (0.59 to 0.60) 0.02
Remove set C 0.89 (0.89 to 0.89) 0.05 0.44 (0.44 to 0.44) 0.18
Remove set D 0.93 (0.93 to 0.93) 0.01 0.60 (0.60 to 0.61) 0.01
Remove set E 0.94 (0.94 to 0.94) 0.001 0.61 (0.61 to 0.62) 0.002
Remove set F 0.94 (0.94 to 0.94) 0 0.62 (0.61 to 0.62) 0
IDH-2 Remove set A 0.87 (0.87 to 0.87) 0.001 0.78 (0.78 to 0.78) 0.002
Remove set B 0.86 (0.86 to 0.86) 0.01 0.76 (0.76 to 0.76) 0.02
Remove set C 0.73 (0.73 to 0.74) 0.14 0.57 (0.56 to 0.57) 0.22
Remove set D 0.86 (0.86 to 0.86) 0.01 0.77 (0.77 to 0.78) 0.01
Remove set E 0.87 (0.87 to 0.87) 0.001 0.78 (0.78 to 0.78) 0.001
Remove set F 0.87 (0.87 to 0.87) −0.001 0.78 (0.78 to 0.78) 0
IDH-3 Remove set A 0.79 (0.79 to 0.79) 0.001 0.51 (0.51 to 0.51) 0.003
Remove set B 0.77 (0.77 to 0.78) 0.02 0.48 (0.48 to 0.48) 0.03
Remove set C 0.70 (0.70 to 0.71) 0.09 0.38 (0.37 to 0.38) 0.14
Remove set D 0.78 (0.77 to 0.78) 0.01 0.49 (0.49 to 0.49) 0.02
Remove set E 0.79 (0.79 to 0.79) 0.002 0.51 (0.51 to 0.51) 0.003
Remove set F 0.79 (0.79 to 0.79) 0 0.51 (0.51 to 0.51) 0.002

IDH-1, intradialytic hypotension defined as nadir systolic BP <90 mm Hg; IDH-2, intradialytic hypotension defined as decrease in systolic BP ≥20 mm Hg and/or decrease in mean arterial pressure ≥10 mm Hg on the basis of BP at initial time point; IDH-3, intradialytic hypotension defined as decrease in systolic BP ≥20 mm Hg and/or decrease in mean arterial pressure ≥10 mm Hg on the basis of BP at prediction time point. Each set contains features as follows: A, age and sex; B, hemodialysis-related features; C, vital signs; D, comorbidities; E, laboratory findings; and F, medications.